BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27070849)

  • 1. Activation and Reactivity of a Bispidine Analogue of Cisplatin: A Theoretical Investigation.
    Graziani V; Coletti C; Marrone A; Re N
    J Phys Chem A; 2016 Jul; 120(27):5175-86. PubMed ID: 27070849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bispidine analogues of cisplatin, carboplatin, and oxaliplatin. synthesis, structures, and cytotoxicity.
    Cui H; Goddard R; Pörschke KR; Hamacher A; Kassack MU
    Inorg Chem; 2014 Apr; 53(7):3371-84. PubMed ID: 24665859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined experimental and computational study on the sulfoxidation by high-valent iron bispidine complexes.
    Jaccob M; Comba P; Maurer M; Vadivelu P; Venuvanalingam P
    Dalton Trans; 2011 Nov; 40(42):11276-81. PubMed ID: 21959496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Structures of 9-Oxabispidine Analogues of Cisplatin, Carboplatin, and Oxaliplatin.
    Pollak D; Goddard R; Pörschke KR
    Inorg Chem; 2016 Sep; 55(18):9424-35. PubMed ID: 27603202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexadentate bispidine derivatives as versatile bifunctional chelate agents for copper(II) radioisotopes.
    Juran S; Walther M; Stephan H; Bergmann R; Steinbach J; Kraus W; Emmerling F; Comba P
    Bioconjug Chem; 2009 Feb; 20(2):347-59. PubMed ID: 19173600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholase activity of dicopper(II)-bispidine complexes: stabilities and structures of intermediates, kinetics and reaction mechanism.
    Born K; Comba P; Daubinet A; Fuchs A; Wadepohl H
    J Biol Inorg Chem; 2007 Jan; 12(1):36-48. PubMed ID: 16964505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquation of the ruthenium-based anticancer drug NAMI-A: a density functional study.
    Besker N; Coletti C; Marrone A; Re N
    J Phys Chem B; 2008 Apr; 112(13):3871-5. PubMed ID: 18331025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrolysis theory for cisplatin and its analogues based on density functional studies.
    Zhang Y; Guo Z; You XZ
    J Am Chem Soc; 2001 Sep; 123(38):9378-87. PubMed ID: 11562220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear free energy relationship for 4-substituted (o-phenylenediamine)platinum(II) dichloride derivatives using quantum mechanical descriptors.
    Costa LA; Rocha WR; De Almeida WB; Dos Santos HF
    J Inorg Biochem; 2005 Feb; 99(2):575-83. PubMed ID: 15621292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, bonding, and catecholase mechanism of copper bispidine complexes.
    Comba P; Martin B; Muruganantham A; Straub J
    Inorg Chem; 2012 Sep; 51(17):9214-25. PubMed ID: 22909271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of amine from platinum(II) complexes: implications for cisplatin inactivation, storage, and resistance.
    Lau JK; Deubel DV
    Chemistry; 2005 Apr; 11(9):2849-55. PubMed ID: 15744707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bispidin-9,9-diol Analogues of Cisplatin, Carboplatin, and Oxaliplatin: Synthesis, Structures, and Cytotoxicity.
    Cui H; Goddard R; Pörschke KR; Hamacher A; Kassack MU
    Inorg Chem; 2016 Mar; 55(6):2986-97. PubMed ID: 26918619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical study of cisplatin binding to DNA: the importance of initial complex stabilization.
    Raber J; Zhu C; Eriksson LA
    J Phys Chem B; 2005 Jun; 109(21):11006-15. PubMed ID: 16852341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
    J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
    Malina J; Natile G; Brabec V
    Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispidine as a Privileged Scaffold.
    Tomassoli I; Gündisch D
    Curr Top Med Chem; 2016; 16(11):1314-42. PubMed ID: 26369817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study.
    Deubel DV
    J Am Chem Soc; 2006 Feb; 128(5):1654-63. PubMed ID: 16448139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.
    Kostrhunova H; Vrana O; Suchankova T; Gibson D; Kasparkova J; Brabec V
    Chem Res Toxicol; 2010 Nov; 23(11):1833-42. PubMed ID: 20939593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of the "piano-stool" [ruthenium(II) (eta6-arene)(en)CL]+ complexes with water and nucleobases; ab initio and DFT study.
    Futera Z; Klenko J; Sponer JE; Sponer J; Burda JV
    J Comput Chem; 2009 Sep; 30(12):1758-70. PubMed ID: 19090568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spin-crossover in an iron(III)-bispidine-alkylperoxide system.
    Bautz J; Comba P; Que L
    Inorg Chem; 2006 Sep; 45(18):7077-82. PubMed ID: 16933906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.